Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

<< Back to News

04/18/17 RC -- adalimumab (Humira) loading dose order set update

The updated adalimumab order set for loading dose in Crohn’s disease and ulcerative colitis is now available on Docushare. The main change is elimination of benefit verification by hospital based social workers- this will now be done by nurse practitioner/MD office staff in outpatient setting. The nurse practitioner will also initiate paperwork to provide a home health nurse in the outpatient setting. The dose does not have to be held pending benefit verification anymore. However, the dose still must be held pending the results of diagnostics for TB (i.e. TB skin test, chest x-ray, or QuantiFERON Gold) and the Hepatitis B panel if ordered. The TB diagnostic may be deferred if that specific diagnostic has already been recently completed. Let Richard know if you have any questions about this revised version.


Humira order set


adalimumab (Humira) monograph






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.